<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03993340</url>
  </required_header>
  <id_info>
    <org_study_id>4-2018-1148</org_study_id>
    <nct_id>NCT03993340</nct_id>
  </id_info>
  <brief_title>Rescue Stenting for Failed Endovascular Thrombectomy in Acute Ischemic Stroke (ReSET)</brief_title>
  <official_title>Rescue Stenting for Failed Endovascular Thrombectomy in Acute Ischemic Stroke (ReSET)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, open-label, multi-center, registry study, designed to show that&#xD;
      rescue stenting is safe and effective for emergency large vessel occlusion (ELVO) patients&#xD;
      who have mechanical thrombectomy failure. Participants with ELVO will initially underwent&#xD;
      mechanical thrombectomy usig stent retriever, contact aspiration or both. After failure of&#xD;
      mechanical thrombectomy, rescue stenting will be performed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 24, 2019</start_date>
  <completion_date type="Actual">July 30, 2021</completion_date>
  <primary_completion_date type="Actual">July 5, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>modified Rankin scale</measure>
    <time_frame>3 months</time_frame>
    <description>The rate of good functional outcome defined by modified Rankin Scale score, 0 - 2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patency of the target artery</measure>
    <time_frame>1 day to 28 days</time_frame>
    <description>The rate of patency of the treated artery at follow-up vascular imaging (magnetic resonance angiography, computed tomography angiography, or catheter angiography)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">78</enrollment>
  <condition>Acute Ischemic Stroke</condition>
  <condition>Intracranial Artery Occlusion</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Rescue stenting group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Rescue stenting</intervention_name>
    <description>The subjects will receive endovascular treatment for acute stroke according to standard clinical practice. Specifically, modern endovascular thrombectomy using a stent retriever, contact aspiration thrombectomy, or both are allowed. The number of thrombectomy attempts is at the operator's discretion. After failure of standard thrombectomy procedure, rescue stenting with Solitaire will be done. Additional balloon angioplasty, glycoprotein IIb/IIIa inhibitor (GPI), or thrombolytic infusions are optional and at the operator's discretion. After successful recanalization with rescue stenting, intravenous maintenance of GPI at least for a 12 hours and then changed to oral antiplatelet are recommended.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with emergent large vessel occlusion and who have not achieved successful&#xD;
        recanalization (defined by mTICI, 2b or 3) by mechanical thrombectomy using stent retriever&#xD;
        or aspiration thrombectomy.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1. Subjects experiencing acute ischemic stroke due to large vessel occlusion&#xD;
             (intracranial internal carotid artery and middle cerebral artery M1 segment)&#xD;
&#xD;
          -  2. Age 19 or greater&#xD;
&#xD;
          -  3. mRS before qualifying stroke, 0 or 1&#xD;
&#xD;
          -  4. Baseline NIHSS score 4 or more&#xD;
&#xD;
          -  5. CT ASPECTS &gt; 6 or MR ASPECTS &gt; 5&#xD;
&#xD;
          -  6. Good collateral statues on CT angiogram (collateral grade by Calgary group, 4 or 5)&#xD;
             or corresponding to DEFUSE 3 or DAWN trial on perfusion imaging.&#xD;
&#xD;
          -  7. Onset (last-seen-well) time to femoral puncture time &lt; 24 hours&#xD;
&#xD;
          -  8. Failure of mechanical thrombectomy with stent retriever, contact aspiration or both&#xD;
&#xD;
          -  9. Subjects who received rescue stenting after failure of mechanical thrombectomy&#xD;
&#xD;
          -  10. Anticipated life expectancy of at least 12 months&#xD;
&#xD;
          -  11. Signed informed consent for study enrollment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1. Any contraindication to antiplatelet medication&#xD;
&#xD;
          -  2. Multiple simultaneous large vessel occlusions&#xD;
&#xD;
          -  3. Pregnancy&#xD;
&#xD;
          -  4. Severe contrast allergy or absolute contraindication to iodinated contrast agent&#xD;
&#xD;
          -  5. Patient has a severe or fatal combined illness that will prevent improvement of&#xD;
             follow-up or will render the procedure unlikely to benefit the patient.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Severance Hospital Stroke Center, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <state>Yeonsei-ro Seodaemun-gu</state>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>June 19, 2019</study_first_submitted>
  <study_first_submitted_qc>June 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 20, 2019</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

